A multi-centre, randomised, double-blinded, controlled,

Project: Research project

Description

A multi-centre, randomised, double-blinded, controlled, dose-escalation trial on safety and efficacy of activated recombiant FVII analogue
StatusActive
Effective start/end date5/22/0712/31/20

Funding

  • NOVO NORDISK

Fingerprint

Safety